obesity drug news today glp-1 october 21 2025 Novo Nordisk fights to keep Medicaid paying for weight-loss drugs GLP-1 brands: Eli Lilly is

Case Study #3: Athletic Performance Optimization Patient: 38-year-old male competitive age-group triathlete Chief Complaints: Declining recovery between training sessions, persistent low-grade injuries, inability to hit previous power numbers despite consistent training Baseline Assessment: IGF-1: 168 ng/mL (suboptimal for training load) Testosterone: 512 ng/dL (adequate but not optimal for performance goals) hs-CRP: 2.1 mg/L (chronic low-grade inflammation) Ferritin: 32 ng/mL (suboptimal for endurance athlete) Training metrics: 7-day recovery time after hard sessions (goal: 2-3 days) Treatment Protocol: Foundation: Address iron deficiency with supplementation, optimize nutrition timing around training Hormone optimization: Testosterone enanthate to achieve 850-950 ng/dL range Peptide therapy: Sermorelin 400 mcg nightly, 6 nights/week (timed around training schedule) Supporting interventions: Sleep optimization protocol, targeted anti-inflammatory nutrition 16-Week Results: IGF-1: 284 ng/mL (+69%) Recovery time: 2-3 days for hard sessions (71% improvement) FTP (functional threshold power): +18 watts Body composition: -2.1% body fat, +1.9 kg lean mass hs-CRP: 0.6 mg/L (normalized) Race results: Two age-group podiums in half-iron distance races Patient Report: The recovery improvement is dramatic

Potentiation of cisplatin cytotoxicity in resistant ovarian cancer SKOV3/cisplatin cells by quercetin pre-treatment

doi: 10.1210/jcem-64-1-190 20 ErbilDErenCYDemirelCKucukerMUSolarogluIEserHY

This mechanism means L-Carnitine is most effective when you are actually exercising, specifically during steady-state or moderate-intensity cardiovascular training where fat is the primary fuel source

Vitalize and protect with a B12 injection for more energy and stronger immunity

[24] However, the similarity of the clinical presentations to those of the malignant counterparts places patients at risk, and therefore, histologic sampling is essential in all oral melanocytic nevi (especially those located in the palate, the most common site of oral melanoma) to exclude and presumably prevent such transformation